Alterity Therapeutics Limited (ATHE): Price and Financial Metrics

Alterity Therapeutics Limited (ATHE): $1.05

0.07 (-6.25%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add ATHE to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#263 of 485

in industry

ATHE Price/Volume Stats

Current price $1.05 52-week high $5.41
Prev. close $1.12 52-week low $1.01
Day low $1.05 Volume 16,600
Day high $1.11 Avg. volume 43,878
50-day MA $1.23 Dividend yield N/A
200-day MA $1.67 Market Cap 7.67M

ATHE Stock Price Chart Interactive Chart >


Alterity Therapeutics Limited (ATHE) Company Bio


Alterity Therapeutics Limited researches and develops therapeutic drugs for the treatment of Parkinsonian's disease and other neurodegenerative diseases in Australia. The company's lead drug candidates is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 for used as an antimicrobial agent. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. The company was founded in 1997 and is based in Melbourne, Australia.


ATHE Latest News Stream


Event/Time News Detail
Loading, please wait...

ATHE Latest Social Stream


Loading social stream, please wait...

View Full ATHE Social Stream

ATHE Price Returns

1-mo -12.50%
3-mo -19.23%
6-mo -47.50%
1-year -36.75%
3-year -89.71%
5-year -89.35%
YTD -57.83%
2023 -28.49%
2022 -51.64%
2021 -46.27%
2020 71.79%
2019 -39.06%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!